Cargando...
Erythropoietin Molecules to Treat Acute Ischemic Stroke: A Translational Dilemna!
IMPORTANCE OF THE FIELD: Since the realization that Erythropoietin (EPO) molecules have “neuroprotective” properties, they have been investigated as treatments for acute ischemic stroke (AIS), but not systematically. The results of the 2009 clinical trial showed that EPO was ineffective as a stroke...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2947745/ https://ncbi.nlm.nih.gov/pubmed/20828227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2010.517954 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|